One-Time gene shot could train body to fight blood cancers
NCT ID NCT06539338
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 17 times
Summary
This early study tests a one-time gene therapy called INT2104 in 10 adults whose B-cell cancers have returned or not responded to other treatments. The therapy is designed to create cancer-fighting T cells and natural killer cells inside the body after a single IV infusion. The main goal is to check safety, but researchers will also look for signs that the treatment is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital MD Anderson
Madrid, 28033, Spain
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.